mSystems,
Journal Year:
2020,
Volume and Issue:
5(2)
Published: March 30, 2020
Gut
microbiota
is
considered
to
play
a
role
in
disease
progression,
and
previous
studies
have
reported
an
association
of
microbiome
dysbiosis
with
T2D.
In
this
study,
we
attempted
investigate
gut
ND,
PreDMs,
NewDMs,
KnownDMs.
We
found
that
the
genera
Akkermansia
Blautia
decreased
significantly
(
P
<
0.05)
treatment-naive
diabetics
were
restored
KnownDMs
on
antidiabetic
treatment.
To
best
our
knowledge,
comparative
shifts
microbial
community
individuals
different
diabetic
states
are
lacking.
Understanding
transition
its
serum
biomarkers
may
pave
way
for
new
therapeutic
approaches
Frontiers in Nutrition,
Journal Year:
2019,
Volume and Issue:
6
Published: March 13, 2019
The
gastrointestinal
tract
with
its
microbiota
is
a
complex,
open
and
integrated
ecosystem
high
environmental
exposure.
It
widely
accepted
that
the
healthy
gut
essential
for
host
homeostasis
immunostasis,
harboring
an
enormous
number
variety
of
microorganisms
genes
tailored
by
hundreds
exogenous
intrinsic
factors.
occurrence
dysbiosis
may
contribute
to
vulnerability
progression
large
spectrum
infectious
non-communicable
diseases,
including
diabetes
obesity,
two
metabolic
disorders
are
showing
endemic
trend
nowadays.
There
urgent
need
develop
efficient
strategies
prevent
treat
such
as
obesity
which
areoften
associated
serious
complications.
In
this
paper,
we
give
overview
on
implications
in
diabesity,
focus
triangle
–
diet
-
metabolism
way
manipulate
microbial
towards
achieving
novel
diagnosis
predictive
biomarkers
final
goal
re-establishing
condition.
current
research
data
regarding
precision/personalized
nutrition
suggest
dietary
interventions,
administration
pre-,
pro-,
synbiotics,
well
antibiotic
treatment
should
be
individually
chronic
diseases
based
genetic
background,
food
beverage
consumption,
nutrient
intake,
microbiome,
metabolome
other
omic
profiles.
Critical Reviews in Food Science and Nutrition,
Journal Year:
2018,
Volume and Issue:
59(6), P. 848 - 863
Published: Dec. 20, 2018
Diabetes
mellitus
(DM)
and
its
complications
are
major
public
health
concerns
which
strongly
influence
the
quality
of
humans'
life.
Modification
gut
microbiota
has
been
widely
used
for
management
diabetes.
In
this
review,
relationship
between
diabetes
microbiota,
as
well
effects
different
dietary
components
traditional
Chinese
medicine
(TCM)
on
microflora
summarized.
Dietary
compounds
TCM
possessing
bioactive
(fiber
phytochemicals)
first
change
composition
(inhibiting
pathogens
promoting
beneficial
bacteria
growth)
then
production
their
metabolites,
would
further
modify
intestinal
environment
through
inhibiting
detrimental
(such
lipopolysaccharide,
hydrogen
sulfide,
indol,
etc.).
Importantly,
metabolites
(short
chain
fatty
acids
other
components)
fermented/degraded
by
can
target
multiple
pathways
in
intestine,
liver,
pancreas,
etc.,
resulting
improvement
health,
glycemic
control,
lipids
profile,
insulin
resistance
inflammation.
Furthermore,
understanding
interaction
underlying
mechanisms
help
design
diet
formula
Further
researches
could
focus
combination
preventing
treating
diabetes,
based
principle
"multiple
against
targets"
from
perspective
microbiota.
Food & Function,
Journal Year:
2019,
Volume and Issue:
10(9), P. 5804 - 5815
Published: Jan. 1, 2019
Lactobacillus
acidophilus
alleviates
type
2
diabetes
induced
by
a
high
fat
diet
and
streptozotocin
(STZ)
injection
regulating
gut
microbiota,
hepatic
glucose
lipid
metabolism
in
mice.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2021,
Volume and Issue:
11
Published: Aug. 19, 2021
Hyperlipidemia,
defined
as
the
presence
of
excess
fat
or
lipids
in
blood,
has
been
considered
a
high-risk
factor
and
key
indicator
many
metabolic
diseases.
The
gut
microbiota
reported
playing
vital
role
regulating
host
lipid
metabolism.
pathogenic
development
hyperlipidemia
revealed
through
fecal
transplantation
experiment
to
germ-free
mice.
effector
mechanism
microbiota-related
metabolites
such
bile
acids,
lipopolysaccharide,
short-chain
fatty
acids
regulation
partially
unveiled.
Moreover,
studies
on
gut-microbiota-targeted
interventions,
including
use
prebiotics,
probiotics,
transplantation,
natural
herbal
medicines,
also
have
shown
their
efficacy
treatment
hyperlipidemia.
In
this
review,
we
summarize
relationship
between
hyperlipidemia,
impact
progression
potential
therapeutic
management
targeted
at
microbiota.
Mediators of Inflammation,
Journal Year:
2021,
Volume and Issue:
2021, P. 1 - 12
Published: Aug. 17, 2021
Gut
microbiota
has
attracted
widespread
attention
due
to
its
crucial
role
in
disease
pathophysiology,
including
type
2
diabetes
mellitus
(T2DM).
Metabolites
and
bacterial
components
of
gut
affect
the
initiation
progression
T2DM
by
regulating
inflammation,
immunity,
metabolism.
Short-chain
fatty
acids,
secondary
bile
acid,
imidazole
propionate,
branched-chain
amino
lipopolysaccharide
are
main
molecules
related
T2DM.
Many
studies
have
investigated
T2DM,
particularly
those
butyrate-producing
bacteria.
Increasing
evidence
demonstrated
that
fecal
transplantation
probiotic
capsules
useful
strategies
preventing
diabetes.
In
this
review,
we
aim
elucidate
complex
association
between
metabolism,
immune
disorders,
underlying
mechanisms,
translational
applications
microbiota.
This
review
will
provide
novel
insight
into
developing
individualized
therapy
for
patients
based
on
immunometabolism.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
160, P. 114344 - 114344
Published: Feb. 2, 2023
All
species
have
a
physiological
need
for
sleep,
and
sleep
is
crucial
the
preservation
restoration
of
many
processes
in
body.
Recent
research
on
effects
gut
microbiota
brain
function
has
produced
essential
data
relationship
between
them.
It
been
discovered
that
dysregulation
gut-brain
axis
related
to
insomnia.
Certain
metabolites
linked
insomnia,
disturbances
can
worsen
Traditional
Chinese
medicine
(TCM)
unique
advantages
treatment
Taking
as
target
determining
scientific
relevance
TCM
prevention
insomnia
may
lead
new
concepts
disorders
improve
therapeutic
effect
sleep.
an
entry
point,
this
paper
reviews
TCM,
mechanism
by
which
regulate
regulates
treatment.
This
review
provides
ideas
through
drug
development.
Microbiome,
Journal Year:
2020,
Volume and Issue:
8(1)
Published: Aug. 19, 2020
Abstract
Background
Variability
in
the
health
effects
of
dietary
fiber
might
arise
from
inter-individual
differences
gut
microbiota’s
ability
to
ferment
these
substrates
into
beneficial
metabolites.
Our
understanding
what
drives
this
individuality
is
vastly
incomplete
and
will
require
an
ecological
perspective
as
microbiomes
function
complex
inter-connected
communities.
Here,
we
performed
a
parallel
two-arm,
exploratory
randomized
controlled
trial
31
adults
with
overweight
class-I
obesity
characterize
long-chain,
arabinoxylan
(
n
=
15)
at
high
supplementation
doses
(female:
25
g/day;
male:
35
g/day)
on
microbiota
composition
short-chain
fatty
acid
production
compared
microcrystalline
cellulose
16,
non-fermentable
control),
integrated
findings
using
framework.
Results
Arabinoxylan
resulted
global
shift
fecal
bacterial
community
composition,
reduced
α-diversity,
promotion
specific
taxa,
including
operational
taxonomic
units
related
Bifidobacterium
longum
,
Blautia
obeum
Prevotella
copri
.
further
increased
propionate
concentrations
p
0.012,
Friedman’s
test),
effect
that
showed
two
distinct
groupings
temporal
responses
participants.
The
groups
compositional
shifts
≤
0.025,
PERMANOVA),
multiple
linear
regression
(MLR)
analyses
revealed
response
was
predictable
through
and,
lesser
degree,
baseline
microbiota.
Principal
components
(PCs)
derived
data
were
better
predictors
MLR
models
single
indicating
fermentation
result
multi-species
interactions
within
microbiomes.
Conclusion
This
study
long-chain
modulates
both
output
health-relevant
SCFAs,
providing
information
for
more
targeted
application
fiber.
Variation
linked
PCs
microbial
showing
strongest
associations.
These
constitute
proof-of-concept
merit
framework
considers
features
wider
prediction
metabolic
outcomes
fermentation.
provides
basis
personalize
use
nutritional
stratify
human
populations
by
relevant
account
inconsistent
intervention
studies.
Trial
registration
Clinicaltrials.gov,
NCT02322112
registered
July
3,
2015.
Protein & Cell,
Journal Year:
2020,
Volume and Issue:
12(5), P. 394 - 410
Published: Sept. 15, 2020
Traditional
Chinese
Medicine
(TCM)
has
been
extensively
used
to
ameliorate
diseases
in
Asia
for
over
thousands
of
years.
However,
owing
a
lack
formal
scientific
validation,
the
absence
information
regarding
mechanisms
underlying
TCMs
restricts
their
application.
After
oral
administration,
TCM
herbal
ingredients
frequently
are
not
directly
absorbed
by
host,
but
rather
enter
intestine
be
transformed
gut
microbiota.
The
microbiota
is
microbial
community
living
animal
intestines,
and
functions
maintain
host
homeostasis
health.
Increasing
evidences
indicate
that
herbs
closely
affect
composition,
which
associated
with
conversion
components
into
active
metabolites.
These
may
significantly
therapeutic
activity
TCMs.
Microbiota
analyses,
conjunction
modern
multiomics
platforms,
can
together
identify
novel
functional
metabolites
form
basis
future
research.
Genomics Proteomics & Bioinformatics,
Journal Year:
2020,
Volume and Issue:
18(6), P. 721 - 736
Published: Dec. 1, 2020
Abstract
Gegen
Qinlian
Decoction
(GQD),
a
traditional
Chinese
medicine
(TCM)
formula,
has
long
been
used
for
the
treatment
of
common
metabolic
diseases,
including
type
2
diabetes
mellitus.
However,
main
limitation
its
wider
application
is
ingredient
complexity
this
formula.
Thus,
it
critically
important
to
identify
major
active
ingredients
GQD
and
illustrate
mechanisms
underlying
action.
Here,
we
compared
effects
berberine,
hypothetical
key
pharmaceutical
GQD,
on
diabetic
rat
model
by
comprehensive
analyses
gut
microbiota,
short-chain
fatty
acids,
proinflammatory
cytokines,
ileum
transcriptomics.
Our
results
show
that
berberine
had
similar
lowering
blood
glucose
levels,
modulating
inducing
ileal
gene
expression,
as
well
relieving
systemic
local
inflammation.
As
expected,
both
significantly
altered
overall
microbiota
structure
enriched
many
butyrate-producing
bacteria,
Faecalibacterium
Roseburia,
thereby
attenuating
intestinal
inflammation
glucose.
Levels
acids
in
feces
were
also
elevated
after
with
or
GQD.
Moreover,
concentration
serum
cytokines
expression
immune-related
genes,
Nfkb1,
Stat1,
Ifnrg1,
pancreatic
islets
reduced
treatment.
study
demonstrates
can
be
attributed
via
microbiota.
The
strategy
employed
would
facilitate
further
standardization
widespread
TCM
diseases.